BACKGROUND: This randomized, double-blind study investigated the efficacy of continuous and patient-controlled ropivacaine infusion via a popliteal sciatic perineural catheter in ambulatory patients undergoing moderately painful orthopedic surgery of the foot or ankle. METHODS: Preoperatively, patients (n = 30) received a posterior popliteal sciatic perineural catheter and nerve block. Postoperatively, patients were discharged home with a portable infusion pump delivering 0.2% ropivacaine (500 ml) in one of three dosing regimens: the basal group (12-ml/h basal rate, 0.05-ml patient-controlled bolus dose), the basal-bolus group (8-ml/h basal rate, 4-ml bolus dose), or the bolus group (0.3-ml/h basal rate, 9.9-ml bolus dose). RESULTS: The bolus group experienced an increase in baseline pain, breakthrough pain incidence and intensity, and sleep disturbances compared with the other two groups (P < 0.05 for all comparisons). Compared with the basal-bolus group, the basal group experienced an increase in these outcome measures only after local anesthetic reservoir exhaustion, which occurred earlier than in the other two groups (P < 0.05 for all comparisons). Satisfaction scores did not differ among the three groups. CONCLUSIONS: This study demonstrates that when providing analgesia with 0.2% ropivacaine via a popliteal sciatic perineural catheter after moderately painful surgery of the foot or ankle, a continuous infusion is required to optimize infusion benefits. Furthermore, adding patient-controlled bolus doses allows for a lower continuous basal rate and decreased local anesthetic consumption and thereby increases the duration of infusion benefits when in an ambulatory environment with a limited local anesthetic reservoir.
RCT Entities:
BACKGROUND: This randomized, double-blind study investigated the efficacy of continuous and patient-controlled ropivacaine infusion via a popliteal sciatic perineural catheter in ambulatory patients undergoing moderately painful orthopedic surgery of the foot or ankle. METHODS: Preoperatively, patients (n = 30) received a posterior popliteal sciatic perineural catheter and nerve block. Postoperatively, patients were discharged home with a portable infusion pump delivering 0.2% ropivacaine (500 ml) in one of three dosing regimens: the basal group (12-ml/h basal rate, 0.05-ml patient-controlled bolus dose), the basal-bolus group (8-ml/h basal rate, 4-ml bolus dose), or the bolus group (0.3-ml/h basal rate, 9.9-ml bolus dose). RESULTS: The bolus group experienced an increase in baseline pain, breakthrough pain incidence and intensity, and sleep disturbances compared with the other two groups (P < 0.05 for all comparisons). Compared with the basal-bolus group, the basal group experienced an increase in these outcome measures only after local anesthetic reservoir exhaustion, which occurred earlier than in the other two groups (P < 0.05 for all comparisons). Satisfaction scores did not differ among the three groups. CONCLUSIONS: This study demonstrates that when providing analgesia with 0.2% ropivacaine via a popliteal sciatic perineural catheter after moderately painful surgery of the foot or ankle, a continuous infusion is required to optimize infusion benefits. Furthermore, adding patient-controlled bolus doses allows for a lower continuous basal rate and decreased local anesthetic consumption and thereby increases the duration of infusion benefits when in an ambulatory environment with a limited local anesthetic reservoir.
Authors: Brian M Ilfeld; Navparkash S Sandhu; Vanessa J Loland; Sarah J Madison; Preetham J Suresh; Edward R Mariano; Michael L Bishop; Alexandra K Schwartz; Daniel K Lee Journal: Reg Anesth Pain Med Date: 2011 May-Jun Impact factor: 6.288
Authors: Maria Bauer; Lu Wang; Olusegun K Onibonoje; Chad Parrett; Daniel I Sessler; Loran Mounir-Soliman; Sherif Zaky; Viktor Krebs; Leonard T Buller; Michael C Donohue; Jennifer E Stevens-Lapsley; Brian M Ilfeld Journal: Anesthesiology Date: 2012-03 Impact factor: 7.892
Authors: S J Madison; A M Monahan; R R Agarwal; T J Furnish; E J Mascha; Z Xu; M C Donohue; A C Morgan; B M Ilfeld Journal: Br J Anaesth Date: 2014-09-23 Impact factor: 9.166
Authors: Brian M Ilfeld; Edward R Mariano; Sarah J Madison; Vanessa J Loland; NavParkash S Sandhu; Preetham J Suresh; Michael L Bishop; T Edward Kim; Michael C Donohue; Anna A Kulidjian; Scott T Ball Journal: Anesth Analg Date: 2011-04-05 Impact factor: 5.108
Authors: Edward R Mariano; Vanessa J Loland; NavParkash S Sandhu; Michael L Bishop; Daniel K Lee; Alexandra K Schwartz; Paul J Girard; Eliza J Ferguson; Brian M Ilfeld Journal: Can J Anaesth Date: 2010-08-11 Impact factor: 5.063
Authors: Brian M Ilfeld; Linda T Le; R Scott Meyer; Edward R Mariano; Krista Vandenborne; Pamela W Duncan; Daniel I Sessler; F Kayser Enneking; Jonathan J Shuster; Douglas W Theriaque; Linda F Berry; Eugene H Spadoni; Peter F Gearen Journal: Anesthesiology Date: 2008-04 Impact factor: 7.892
Authors: Brian M Ilfeld; Vanessa J Loland; J C Gerancher; Anupama N Wadhwa; Elizabeth M Renehan; Daniel I Sessler; Jonathan J Shuster; Douglas W Theriaque; Rosalita C Maldonado; Edward R Mariano Journal: Anesth Analg Date: 2008-08 Impact factor: 5.108